Anti-Atopic Dermatitis Effect of Azalomycin F on 2,4-Dinitrofluorobenzene-Induced Mice and Potential Mechanism
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312846 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Wenjia Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnological Engineering Center for Pharmaceutical Research and Development, Jiangxi Agricultural University, Nanchang 330045, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Dinitrofluorobenzene, Cytokines, Immunoglobulin E. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangxi Province Natural Science Foundation.
Abstract (Originalsprache)
Azalomycin F (AZF) is a kind of antibiotic with antifungal and antibacterial activities, as well as anti-inflammatory and anti-tumor activities. In this study, we evaluated the effects of AZF on atopic dermatitis (AD) and its possible molecular mechanisms. Mice with 2,4-dinitrofluorobenzene-induced AD-like skin lesions were topically treated with 10–30 mg/kg AZF on their dorsal skin for 12 days. Observations focused on skin lesion scores, the frequency of scratching, and histopathological alterations in the skin. In addition, IgE and inflammatory cytokine levels in serum were assessed. The results indicated that topical application of 10–20 mg/kg AZF could reduce skin lesion scores and scratching frequencies in AD mice, while 15–20 mg/kg AZF decreased epidermal thickness and mast cell infiltration. Additionally, the serum levels of IgE, IFN-γ, IL-4, TSLP and IL-1β were reduced with 10–20 mg/kg AZF treatment. Moreover, RNA-Seq was employed to reveal the potential molecular mechanisms underlying anti-AD effects of AZF. KEGG enrichment analysis revealed that the most significantly differentially expressed genes are predominantly enriched in signaling pathways such as NF-κB and TNF. Protein–protein interaction network analysis identifies the key genes including Il1b, Tnf, and Cxcl1. In summary, 15 mg/kg AZF effectively alleviates the inflammatory response in AD mice, and the potential mechanism may involve the regulation of key signaling pathways like NF-κB and TNF, thereby reducing inflammatory factor levels and eliciting an anti-inflammatory effect. These findings provide valuable scientific evidence for the development of novel natural drugs for the treatment of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotechnological Engineering Center for Pharmaceutical Research and Development, Jiangxi Agricultural University, Nanchang 330045, China.
- College of Animal Science and Technology, Jiangxi Agricultural University, Nanchang 330045, China.
- Laboratory of Natural Medicine and Microbiological Drug, College of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang 330045, China.
ORCID-Profile: Xinrong Luo, Yanli Yang, Ganjun Yuan
Förderung
- National Natural Science Foundation of China
- Jiangxi Province Natural Science Foundation
Zitieren
APA
Zhao, W., Zhu, J., Luo, X., Lian, F., Yang, Y., He, S., Zhu, J., & Yuan, G. (2024). Anti-Atopic Dermatitis Effect of Azalomycin F on 2,4-Dinitrofluorobenzene-Induced Mice and Potential Mechanism. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312846
Vancouver
Zhao W, Zhu J, Luo X, Lian F, Yang Y, He S, et al. Anti-Atopic Dermatitis Effect of Azalomycin F on 2,4-Dinitrofluorobenzene-Induced Mice and Potential Mechanism. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312846
BibTeX
@article{Zhao2024,
author = {Zhao, Wenjia and Zhu, Jianping and Luo, Xinrong and Lian, Fengxian and Yang, Yanli and He, Su and Zhu, Jinzhou and Yuan, Ganjun},
title = {Anti-Atopic Dermatitis Effect of Azalomycin F on 2,4-Dinitrofluorobenzene-Induced Mice and Potential Mechanism},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312846}
}
EUVIMED